Back to the main directory
Press Release
- OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET by GlobeNewsWire
- Outcrop Silver & Gold to Present at Precious Metals Summit Zurich by Newsfile Corp.
- Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings by GlobeNewsWire
- United Bankshares, Inc. Announces Earnings for the Third Quarter and First Nine Months of 2023 by BusinessWire
- NICE Named Exemplary Leader in Ventana Research 2023 Buyers Guide for Agent Management by BusinessWire
- TELUS achieves historic ISO 31700-1 Privacy by Design certification by GlobeNewsWire
- Aspira Women’s Health Sees Poster on its miRNA-based Ovarian Cancer Test Presented at the AACR Special Conference in Cancer Research by GlobeNewsWire
- Lakeland Financial Reports Net Income of $25.3 Million for the Third Quarter and 10% Annualized Average Loan Growth by GlobeNewsWire
- Alignment Healthcare Medicare Advantage Plan Named to U.S. News & World Report 2024 Best Insurance Companies for Medicare Advantage in North Carolina for Second Consecutive Year by GlobeNewsWire
- American Oncology Network Announces Third Quarter 2023 Earnings Release Date and Conference Call by GlobeNewsWire
- Shoals Technologies to Deploy Fuel by Shoals® eMobility Solution for Department of the Air Force by GlobeNewsWire
- Clean Earth Recycled 8.7 Billion Pounds of Waste in 2022 by GlobeNewsWire
- Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences by GlobeNewsWire
- Anavex Life Sciences Reports New Publication in Scientific Journal Demonstrating the Potential of ANAVEX®3-71 to Prevent Cognitive Decline in Alzheimer’s Disease by GlobeNewsWire
- Aqua Metals to Announce Third Quarter 2023 Financial Results and Host Investor Conference Call on November 8, 2023 by GlobeNewsWire
- HomeTrust Bancshares, Inc. Announces Financial Results for the First Quarter of the Six-Month Transition Period Ending December 31, 2023* and an Increase in the Quarterly Dividend by GlobeNewsWire
- The RaniPill® Capsule, Rani Therapeutics’ Oral Delivery Platform, was Well-Tolerated in 60-Day, Repeat-Administration, GLP Safety Study by GlobeNewsWire
- Immutep receives ~A$1.13 million R&D Tax Incentive by GlobeNewsWire
- Aligos Therapeutics To Present Late Breaking Poster on ALG-000184, its CAM-E Drug Candidate, at The Liver Meeting® 2023 by GlobeNewsWire
- Femasys Inc. to Showcase FemBloc and its other Novel Products Advancing Women’s Health at the American Association of Gynecologic Laparoscopic Surgeons by GlobeNewsWire
- Luckin Coffee to Announce Third Quarter 2023 Financial Results on November 1, 2023 by GlobeNewsWire
- Lifetime Brands, Inc. Announces Launch of an Amendment and Extension of the Company's Existing Term Loan B and Preliminary Results for Third Quarter 2023 by GlobeNewsWire
- EQS-News: EBD Group: The global biopharma community is now actively partnering for BIO-Europe® 2023 by EQS Group AG
- The Healing Company’s Chopra and Swan Hellenic Announce Exclusive, Multi-Year Partnership With Launch of Well-Being Travel Experience “Explore & Restore” by GlobeNewsWire
- Farmers National Banc Corp. Announces Earnings for Third Quarter of 2023 by BusinessWire
- The Vast Majority Of Manufacturing CEOs Say AI Is Delivering Strong ROI As Reshoring Continues To Accelerate, According To Latest Quarterly ‘American Manufacturing Resilience’ Poll With Forbes, Xometry And John Zogby Strategies by GlobeNewsWire
- Alliance Trust PLC - Net Asset Value by GlobeNewsWire
- Kane Biotech to Exhibit at Symposium on Advanced Wound Care Fall Forum by GlobeNewsWire
- Redfin Announces Redfin Max, a Game-Changing Pay Plan for Agents by BusinessWire
- LifeMD to Report Third Quarter 2023 Financial Results on November 8 by GlobeNewsWire
- Katapult to Announce Third Quarter 2023 Financial Results on November 8, 2023 by GlobeNewsWire
- European Wax Center, Inc. to Report Third Quarter Fiscal 2023 Financial Results on November 8th by GlobeNewsWire
- Rhythm Pharmaceuticals to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023 by GlobeNewsWire
- Vertex kündigt strategische Partnerschaft mit Pagero an by GlobeNewsWire
- FTC Solar to Announce Third Quarter Financial Results Wednesday, November 8, 2023 by GlobeNewsWire
- Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2023 Financial Results by GlobeNewsWire
- Health Catalyst to Announce Third Quarter 2023 Operating Results and Host Conference Call on Wednesday, November 8, 2023 by GlobeNewsWire
- Centessa Pharmaceuticals Announces Preclinical Data Supporting ORX750’s Potential as a Best-in-Class Oral OX2R Agonist for the Treatment of Narcolepsy and Other Sleep-Wake Disorders by GlobeNewsWire
- 4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis at 2023 NACFC by GlobeNewsWire
- Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader Webinar by GlobeNewsWire
- Infinera to Announce Fiscal Third Quarter 2023 Financial Results on November 8, 2023 by GlobeNewsWire
- Asia Broadband Completes Mineral Analysis Lab Installation and Begins Targeted Ore Stockpile Testing Campaign by GlobeNewsWire
- 3D Systems Announces Additional Restructuring Initiative and Provides Preliminary Third Quarter 2023 Financial Results by GlobeNewsWire
- Cellectar Biosciences Partners with Florida Cancer Specialists & Research Institute to Support the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting by GlobeNewsWire
- Recce Pharmaceuticals Announces Safety Committee Approves Faster Infusion Rate in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis by GlobeNewsWire
- Ferroglobe PLC Schedules Third Quarter 2023 Earnings Call for November 8, 2023 by GlobeNewsWire
- ODDITY to Announce Third Quarter 2023 Financial Results on November 7, 2023 by GlobeNewsWire
- EQS-News: Nature Communications publication reveals highly efficient AAV delivery of large genes using ViGeneron´s REVeRT technology by EQS Group AG
- EQS-News: Galimedix Appoints Dr. Luciana Summo as Vice President, R&D Operations by EQS Group AG
- Amphenol Reports Third Quarter 2023 Results and Announces Dividend Increase by BusinessWire